Excellence in Neuroscience Nursing Recognized
Natalie Berkiw, Brain Tumour Foundation of Canada’s Information and Education Services Specialist, was delighted to present this year’s Canadian Association of Neuroscience Nurses (CANN) award to Wendy Blackburn, Grace Leung, and Catherine Morash from Sunnybrook and Women’s College Health Sciences Centre.
The annual award recognizes excellence in the area of neuro-oncology nursing and was established in honour of Pamela Del Maestro, a co-founder of Brain Tumour Foundation of Canada. This year’s CANN conference took place on June 22nd in Edmonton, Alberta.
Congratulations to Wendy, Grace, and Catherine for their continued commitment to those affected by a brain tumour.
Funding Brain Tumour Research in 2007
Brain Tumour Foundation of Canada continues to support Canadian researchers in the search to find a cause and cure for brain tumours. This year, we are proud to announce six new research grants awarded across the country.
DR. MICHAEL CUSIMANO
St. Michael’s Hospital, Toronto, Ontario
Project: A driving simulator study of brain tumour patients with focal cerebellar lesions.
DR. JULIETTE HUKIN
BC Children’s Hospital, Vancouver, British Columbia
Project: Evaluation of biomarkers in relation to recurrence rate in childhood ependymoma.
DR. CYNTHIA MENARD
Princess Margaret Hospital, Toronto, Ontario
Project: Hippocampal Radiosurgery Exposure and Memory
DR. SEYED M. MIRSATTARI
London Health Sciences Centre, London, Ontario
Project: Clinical features, epidemiology, pathophysiology, and treatment of epilepsy associated with cerebral oligodendrogliomas in adults and children.
DR. ARU NARENDRAN
Alberta Children’s Hospital, Calgary, Alberta
Project: Little patients are losing patience: Studies to evaluate urgently needed therapeutic agents for the treatment of atypical teratoid rhabdoid tumour of the CNS.
DR. MICHAEL PETRIDES
Montreal Neurological Institute, Montreal, Quebec
Project: Development of new functional neuroimaging tools for the assessment of high-order cognitive functions in patients with low-grade gliomas.